ACS Recommends Increased Patient Navigation During Pandemic
In response to the detrimental impact of the COVID-19 pandemic on cancer screening and care, the American Cancer Society (ACS) released this report that recommends increasing implementation of patient navigation to help people who are underserved and/or most likely to have poor outcomes for all cancer types. This report also includes recommendations such as national partnerships, coordinated messaging, quality measures, pandemic-related innovations, and more.
Assessing the Global Burden of Post–COVID-19 Conditions
This report explains multiple definitions of post-COVID conditions; the challenge to study post-COVID conditions; and the questions surrounding epidemiology, underlying causes, and effective therapeutics and treatment strategies for patients.
FDA Emergency Use Authorization for Drugs and Biological Products
There are many changes and questions regarding drugs and biological agents for cancer treatments during the COVID-19 pandemic. The oncology population may consult the FDA Emergency Use Authorization (EUA) that, since March 27, 2020, authorizes (1) the emergency use of an unapproved drug, an unapproved or uncleared device, or an unlicensed biological product; or (2) an unapproved use of an approved drug, approved or cleared device, or licensed biological product.
NCCN: COVID-19 Vaccination Guide for People with Cancer
The National Comprehensive Cancer Network® (NCCN®) has released new vaccination guidelines for patients with cancer and their caregivers, including recommendations for a third dose of the vaccine.
NCCN Letter of Support for Mandatory Vaccines for Healthcare Workers
In recognition that many navigators use the National Comprehensive Cancer Network® (NCCN®) to ensure the patients with cancer they are navigating are receiving treatment per clinical practice guidelines to improve the quality, effectiveness, and efficiency of oncology practice so patients can live better lives, AONN+ is sharing the NCCN Statement of Support.
Joint Statement in Support of COVID-19 Vaccine Mandates for All Workers in Health and Long-Term Care
A letter of support from multiple healthcare organizations and societies to support COVID-19 vaccine mandates for healthcare workers.
FDA Approves First COVID-19 Vaccine
The FDA has approved the Pfizer-BioNTech COVID-19 vaccine, which will now be marketed as Comirnaty, for the prevention of COVID-19 disease in individuals 16 years of age and older.
National Vaccine Research Study for Transplant Recipients
A new research study is being held to determine COVID-19 antibody levels in transplant recipients who get the COVID-19 vaccine. Enrollment of transplant recipients for this observational study is now open!
Watch COVID-19 vaccines for people with inherited mutations by FORCE
Cancer Support Community Podcast - Spotlight on Coronavirus: Vaccines
NCCN: Cancer and COVID-19 Vaccination Guidance
Fact Sheet for Healthcare Providers Administering Vaccine
Policy Statement: Dissemination of Non-scientific and Misleading COVID-19 Information by Nurses
AONN+ is inclusive of all types of oncology navigators and those who work around them to provide a network for collaboration, leadership, and development of best practices for the improvement of patient access to care, evidence-based cancer treatment, and quality of life. In response to COVID-19 misinformation being spread, we are sharing this policy brief and, although it is aimed at nurses, it can be applicable to all who serve patients. The purpose is to help inform and educate all nurse and patient navigators and the public about the need for healthcare professionals to uphold the highest standards of ethics when it comes to representing their profession.
Smith WR, Atala AJ, Terlecki RP, Kelly EE, Matthews CA, Implementation Guide for Rapid Integration of an Outpatient Telemedicine Program during the COVID-19 Pandemic, Journal of the American College of Surgeons (2020), doi: https://doi.org/10.1016/j.jamcollsurg.2020.04.030.
This team built a toolkit that details 8 essential components to successful implementation of a telemedicine platform: Provider and staff training, patient education, an existing electronic medical record system, patient and provider investment in hardware, billing and coding integration, information technology support, audiovisual platforms, and patient and caregiver participation.
Results: Rapid integration of telemedicine in their practice was required to be compliant with the institution’s COVID-19 Taskforce. Within 3 days of this declaration, their large specialty-care clinic converted to a telemedicine platform and completed 638 visits within the first month of implementation.
CMS Expands Access to Telehealth Benefits During COVID-19 Outbreak
Coping with Stress and Isolation Video by Johns Hopkins Medicine
Have you encountered a problem with link not working or displaying an error message?
Help us fix it!
Privacy Notice | Terms of Use
© 2009- DBA AONN+ Academy of Oncology Nurse & Patient Navigators® | PO Box 563, Cranbury, NJ 08512 |
AONN+ DBA AONN+ is a 501(c)(6) organization under federal tax guidelines. AONN+ Foundation for Learning, Inc. a 501(c)(3) organization under federal tax guidelines.
AONN+ Advantage, LLC, a wholly owned subsidiary of AONN+.